Skip to main content

Insight Molecular Diagnostics Inc.

IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001642380

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Insight Molecular Diagnostics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
−5 vs. Q1 2023
Shares held
91.8M
+36.2M (+65.0%) vs. Q1 2023
Total value
$21.1M
+$1.40M (+7.1%) vs. Q1 2023
New holders
6
13 more added
Sold out
11
7 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 47 institutions
Q1 2021: 87 institutionsQ2 2021: 91 institutionsQ3 2021: 95 institutionsQ4 2021: 89 institutionsQ1 2022: 86 institutionsQ2 2022: 76 institutionsQ3 2022: 65 institutionsQ4 2022: 59 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 30 institutionsQ4 2023: 26 institutionsQ1 2024: 25 institutionsQ2 2024: 23 institutionsQ3 2024: 21 institutionsQ4 2024: 27 institutionsQ1 2025: 30 institutionsQ2 2025: 30 institutionsQ3 2025: 27 institutionsQ4 2025: 35 institutionsQ1 2026: 41 institutionsQ2 2026: 40 institutions
Value heldQ2 2023: $21.1M
Q1 2021: $283.0MQ2 2021: $324.6MQ3 2021: $201.9MQ4 2021: $120.3MQ1 2022: $81.2MQ2 2022: $61.9MQ3 2022: $48.4MQ4 2022: $19.6MQ1 2023: $19.7MQ2 2023: $21.1MQ3 2023: $14.3MQ4 2023: $11.4MQ1 2024: $13.5MQ2 2024: $21.1MQ3 2024: $20.4MQ4 2024: $20.0MQ1 2025: $49.2MQ2 2025: $48.9MQ3 2025: $54.1MQ4 2025: $124.9MQ1 2026: $62.1MQ2 2026: $108.9M
Institutions holding IMDX and their total value by quarter
QuarterHoldersValue
Q2 202640$108.9M
Q1 202641$62.1M
Q4 202535$124.9M
Q3 202527$54.1M
Q2 202530$48.9M
Q1 202530$49.2M
Q4 202427$20.0M
Q3 202421$20.4M
Q2 202423$21.1M
Q1 202425$13.5M
Q4 202326$11.4M
Q3 202330$14.3M
Q2 202347$21.1M
Q1 202352$19.7M
Q4 202259$19.6M
Q3 202265$48.4M
Q2 202276$61.9M
Q1 202286$81.2M
Q4 202189$120.3M
Q3 202195$201.9M
Q2 202191$324.6M
Q1 202187$283.0M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Insight Molecular Diagnostics Inc.; share changes are against Q1 2023.

Institutions holding IMDX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Broadwood Capital Inc50,181,335$11.5M0.86%+26,827,638+114.9%Added
AWM Investment Company, Inc.14,185,664$3.26M0.44%+7,412,613+109.4%Added
Pura Vida Investments, LLC13,625,022$3.13M1.30%−541,141−3.8%Reduced
Vanguard Group Inc4,359,202$1.00M0.00%00.0%Unchanged
Morgan Stanley2,790,933$641.9K0.00%+2,754,399+7,539.3%Added
Defender Capital, LLC.2,327,930$535.1K0.18%−35,500−1.5%Reduced
Geode Capital Management, LLC1,228,553$282.6K0.00%+236,099+23.8%Added
BlackRock Inc.1,212,026$278.8K0.00%−213,360−15.0%Reduced
Millennium Management LLC337,765$77.7K0.00%−136,946−28.8%Reduced
State Street Corp281,845$64.8K0.00%00.0%Unchanged
Citadel Advisors LLC251,952$57.9K0.00%+251,952New
Northern Trust Corp194,911$44.8K0.00%00.0%Unchanged
Renaissance Technologies LLC138,100$32.0K0.00%+78,500+131.7%Added
LPL Financial LLC127,459$29.3K0.00%−20,104−13.6%Reduced
Virtu Financial LLC65,123$15.0K0.00%+65,123New
Two Sigma Securities, LLC51,165$11.8K0.00%+38,686+310.0%Added
Tower Research Capital LLC (TRC)49,797$11.5K0.00%+11,561+30.2%Added
Ameriprise Financial Inc44,700$10.3K0.00%+2,300+5.4%Added
UBS Group AG43,723$10.1K0.00%+24,886+132.1%Added
Bank of New York Mellon Corp42,197$9.71K0.00%−20,910−33.1%Reduced
Wealth Effects LLC40,500$9.31K0.00%00.0%Unchanged
Bank of America Corp34,201$7.87K0.00%+7,913+30.1%Added
Merit Financial Group, LLC32,000$7.36K0.00%00.0%Unchanged
Lee Danner & Bass Inc27,763$6.00K0.00%00.0%Unchanged
HRT Financial LP27,321$6.00K0.00%+27,321New
Advisor Group Holdings, Inc.24,450$5.62K0.00%00.0%Unchanged
Schonfeld Strategic Advisors LLC19,700$4.53K0.00%−1,800−8.4%Reduced
Victory Capital Management Inc16,422$3.78K0.00%+4,592+38.8%Added
Williams Jones Wealth Management, LLC.15,000$3.45K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.14,776$3.40K0.00%00.0%Unchanged
Creative Planning12,136$2.79K0.00%+12,136New
Levin Capital Strategies, L.P.10,500$2.42K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.10,000$2.30K0.00%00.0%Unchanged
Royal Bank of Canada3,345$1.00K0.00%+2,756+467.9%Added
BNP Paribas Arbitrage, SA4,164$9580.00%00.0%Unchanged
JPMorgan Chase & Co3,104$7140.00%00.0%Unchanged
Rhumbline Advisers1,323$3040.00%+1,323New
Wells Fargo & Company1,125$2590.00%+325+40.6%Added
Riggs Asset Managment Co. Inc.1,000$2300.00%00.0%Unchanged
US Bancorp500$1150.00%00.0%Unchanged
Piscataqua Savings Bank500$1150.00%00.0%Unchanged
Meeder Asset Management Inc195$450.00%00.0%Unchanged
Coppell Advisory Solutions LLC205$440.00%+205New
Albion Financial Group152$350.00%00.0%Unchanged
Lindbrook Capital, LLC86$200.00%00.0%Unchanged
Nelson, Van Denburg & Campbell Wealth Management Group, LLC15$30.00%00.0%Unchanged
FMR LLC10$20.00%00.0%Unchanged
Penbrook Management LLC0$00.00%−207,675−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−205,300−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−62,284−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−34,776−100.0%Sold out
Deutsche Bank AG0$00.00%−33,890−100.0%Sold out
Jane Street Group, LLC0$00.00%−24,806−100.0%Sold out
Westshore Wealth, LLC0$00.00%−20,000−100.0%Sold out
Freestone Capital Holdings, LLC0$00.00%−10,000−100.0%Sold out
LMR Partners LLP0$00.00%−10,000−100.0%Sold out
Citigroup Inc0$00.00%−137−100.0%Sold out
Group One Trading, L.P.0$00.00%−24−100.0%Sold out